182 related articles for article (PubMed ID: 22588951)
1. Aldosterone-induced osteopontin expression in vascular smooth muscle cells involves MR, ERK, and p38 MAPK.
Fu GX; Xu CC; Zhong Y; Zhu DL; Gao PJ
Endocrine; 2012 Dec; 42(3):676-83. PubMed ID: 22588951
[TBL] [Abstract][Full Text] [Related]
2. Positive regulation of the Egr-1/osteopontin positive feedback loop in rat vascular smooth muscle cells by TGF-beta, ERK, JNK, and p38 MAPK signaling.
Yu HW; Liu QF; Liu GN
Biochem Biophys Res Commun; 2010 May; 396(2):451-6. PubMed ID: 20417179
[TBL] [Abstract][Full Text] [Related]
3. The case against aldosterone: not proven.
Funder JW
Endocrine; 2012 Dec; 42(3):464-5. PubMed ID: 22820892
[No Abstract] [Full Text] [Related]
4. Blockade of integrin beta3-FAK signaling pathway activated by osteopontin inhibits neointimal formation after balloon injury.
Han M; Wen JK; Zheng B; Liu Z; Chen Y
Cardiovasc Pathol; 2007; 16(5):283-90. PubMed ID: 17868879
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone-induced osteopontin gene transcription in vascular smooth muscle cells involves glucocorticoid response element.
Kiyosue A; Nagata D; Myojo M; Sato T; Takahashi M; Satonaka H; Nagai R; Hirata Y
Hypertens Res; 2011 Dec; 34(12):1283-7. PubMed ID: 21814207
[TBL] [Abstract][Full Text] [Related]
6. Breviscapine inhibits high glucose-induced proliferation and migration of cultured vascular smooth muscle cells of rats via suppressing the ERK1/2 MAPK signaling pathway.
He M; Xue ZM; Li J; Zhou BQ
Acta Pharmacol Sin; 2012 May; 33(5):606-14. PubMed ID: 22465949
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone induces C-reactive protein expression via MR-ROS-MAPK-NF-κB signal pathway in rat vascular smooth muscle cells.
Zhang X; Liu J; Pang X; Zhao J; Wang S; Wu D
Mol Cell Endocrinol; 2014 Sep; 395(1-2):61-8. PubMed ID: 25109280
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation.
Ishizawa K; Izawa Y; Ito H; Miki C; Miyata K; Fujita Y; Kanematsu Y; Tsuchiya K; Tamaki T; Nishiyama A; Yoshizumi M
Hypertension; 2005 Oct; 46(4):1046-52. PubMed ID: 16087789
[TBL] [Abstract][Full Text] [Related]
9. The mineralocorticoid receptor-p38MAPK-NFκB or ERK-Sp1 signal pathways mediate aldosterone-stimulated inflammatory and profibrotic responses in rat vascular smooth muscle cells.
Zhu CJ; Wang QQ; Zhou JL; Liu HZ; Hua F; Yang HZ; Hu ZW
Acta Pharmacol Sin; 2012 Jul; 33(7):873-8. PubMed ID: 22659623
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation.
Mugabe BE; Yaghini FA; Song CY; Buharalioglu CK; Waters CM; Malik KU
J Pharmacol Exp Ther; 2010 Jan; 332(1):116-24. PubMed ID: 19797620
[TBL] [Abstract][Full Text] [Related]
11. Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors.
Nguyen Dinh Cat A; Briones AM; Callera GE; Yogi A; He Y; Montezano AC; Touyz RM
Hypertension; 2011 Sep; 58(3):479-88. PubMed ID: 21788604
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated vascular smooth muscle migration induced by LPA involves p38 mitogen-activated protein kinase pathway activation.
Zhou ZB; Niu JP; Zhang ZJ
Int J Mol Sci; 2009 Jul; 10(7):3194-3208. PubMed ID: 19742132
[TBL] [Abstract][Full Text] [Related]
13. Hepatoma-derived growth factor enhances osteoblastic transformation of rat aortic vascular smooth muscle cells in vitro.
Cheng CI; Chang HR; Tai MH; Chou MH; Chen GT; Chen PH; Kao YH
Life Sci; 2020 Sep; 256():117964. PubMed ID: 32534036
[TBL] [Abstract][Full Text] [Related]
14. Proliferative Vascular Smooth Muscle Cells Stimulate Extracellular Matrix Production via Osteopontin/p38 MAPK Signaling Pathway.
Pei H; Zhang H; Tian C; Sun X; Qian X; Meng Y; Guo X; Chang Q
Cardiology; 2021; 146(5):646-655. PubMed ID: 34186540
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.
Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512
[TBL] [Abstract][Full Text] [Related]
16. P38 MAPK Signaling Pathway Mediates Angiotensin II-Induced miR143/145 Gene Cluster Downregulation during Aortic Dissection Formation.
Li B; Wang Z; Hu Z; Zhang M; Ren Z; Zhou Z; Huang J; Hu X
Ann Vasc Surg; 2017 Apr; 40():262-273. PubMed ID: 28167124
[TBL] [Abstract][Full Text] [Related]
17. CREB-mediated IL-6 expression is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration.
Chava KR; Karpurapu M; Wang D; Bhanoori M; Kundumani-Sridharan V; Zhang Q; Ichiki T; Glasgow WC; Rao GN
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):809-15. PubMed ID: 19342597
[TBL] [Abstract][Full Text] [Related]
18. Farrerol maintains the contractile phenotype of VSMCs via inactivating the extracellular signal-regulated protein kinase 1/2 and p38 mitogen-activated protein kinase signaling.
Liu E; Shi S; Li J; Ge R; Liang T; Li Q
Mol Cell Biochem; 2020 Dec; 475(1-2):249-260. PubMed ID: 32840737
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin attenuates homocysteine-induced migration of smooth muscle cells through mevalonate pathway involving reactive oxygen species and p38 MAPK.
Bao XM; Zheng H
Clin Exp Pharmacol Physiol; 2015 Aug; 42(8):865-73. PubMed ID: 26041506
[TBL] [Abstract][Full Text] [Related]
20. [The effects and mechanisms of high glucose on the phenotype transformation of rat vascular smooth muscle cells].
Zhang J; Chu HR; Guo Y; Liu JH; Li WP; Li H; Cheng M
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 Sep; 31(5):458-61. PubMed ID: 26827542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
